688289 Sansure Biotech Inc.
- 17.74
- -0.06-0.34%
Sansure Biotech Inc. News
Shengxiang Biotechnology Co., Ltd. 2024 First Extraordinary General Meeting of Shareholders Meeting Data
Special verification opinion on the use of part of the over-raised funds of Sansure Biotech Inc. as permanent supplementary working capital by Western Securities Co., Ltd.
Announcement by Sansure Biotech Inc. regarding the use of some of the excess funds to permanently supplement working capital.
Review of Sansure Biotech Inc.'s use of partially idle raised funds for cash management by West Securities Co., Ltd.
Announcement from Sansure Biotech Inc. regarding the use of some temporarily idle raised funds for cash management.
Special report on the use of funds raised and actual usage for the first half of 2024 by Sansure Biotech Inc.
Announcement of Resignation of Director and Nomination of Director Candidates by Sansure Biotech Inc.
Announcement of Sansure Biotech Inc. regarding the change of purposes for part of the repurchased shares and cancellation, as well as the reduction of registered capital.
Announcement from Sansure Biotech Inc. Regarding the Profit Distribution Plan for the First Half of 2024.
The semi-annual evaluation report of the 'Quality Improvement and Efficiency Enhancement, Returning Value' Action Plan for 2024 of Sansure Biotech Inc.
Full text of Sansure Biotech Inc.'s 2024 interim report
Summary of Sansure Biotech Inc.'s 2024 half-yearly report.
Announcement of the resolution of the fourth meeting of the second supervisory board of Sansure Biotech Inc. in 2024.
Notice of sansure biotech inc. on convening the first extraordinary shareholders' meeting of 2024.
Announcement of Sansure Biotech Inc.'s voluntary disclosure of obtaining medical instrument registration certificate for related products.
Announcement of Sansure Biotech Inc.'s voluntary disclosure of obtaining medical instrument registration certificate for related products.
Announcement on the progress of the actual controller and chairman of Sansure Biotech Inc. and their concerted action persons' shareholding, which is more than halfway through.
Announcement on the Results of the First Restricted Stock Incentive Plan for 2023 of Sansure Biotech Inc.
Announcement of Sansure Biotech Inc. regarding the proposal of the actual controller and director to distribute interim dividends, cancel some repurchased shares and implement the "Improving Quality and Efficiency to Achieve Returns" action plan for the company in 2024.
Announcement on the resolution of the fifth interim meeting of the second board of directors of Sansure Biotech Inc. in 2024.
Analysis
Price Target
No Data
